Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journalLetter

16 Scopus citations
Original languageEnglish
Pages (from-to)e408
JournalBlood cancer journal
Volume6
DOIs
StatePublished - Mar 25 2016
Externally publishedYes

Cite this

Ratner, L., Rauch, D., Abel, H., Caruso, B., Noy, A., Barta, S. K., Parekh, S., Ramos, J. C., Ambinder, R., Phillips, A., Harding, J., Baydoun, H. H., Cheng, X., & Jacobson, S. (2016). Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood cancer journal, 6, e408. https://doi.org/10.1038/bcj.2016.21